Cancer Medicine

Article	Citations
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	289
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomics	152
Physical activity, polygenic risk score, and colorectal cancer risk	102
Evaluating implementation of a hospital‐based cancer registry to improve childhood cancer care in low‐ and middle‐income countries	98
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells	98
Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer	83
Characteristics of anal canal cancer in Japan	82
Survival outcomes of combined hepatocellular‐cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population‐based cohort study	82
Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet‐PHL‐C1 Protocol: Experience From a Resource‐Limited Country	81
Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study	75
Social Determinants of Health Predict Sleep–Wake Disturbances Among Patients Living With Primary Brain Tumors: A Cross‐Sectional Analysis	74
Establishing a robust radioligand therapy program: A practical approach for North American centers	70
The Association Between Psychological Distress, Emergency Room Visits, and All‐Cause Mortality Among Colorectal Cancer Survivors	69
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	65
Inflammatory geriatric nutritional risk index stratified the survival of older adults with cancer sarcopenia	65
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes	64
Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study	62
Cardiovascular Medication and Health Service Use in Individuals With Cancer: A Retrospective Population‐Based Cohort Study	55
Racial and ethnic disparities in mortality among World Trade Center Health Registry enrollees with post‐9/11 cancer	55
Issue Information	55
Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis	54
Cuproptosis gene‐related, neural network‐based prognosis prediction and drug‐target prediction for KIRC	53
Issue Information	51
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population	51
Cancer and the family: Variations by sex and race/ethnicity	51

Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer	49
Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis	49
Impact of Body Image Perception on Behavioral Outcomes in Chinese Adolescent and Young Adult Survivors of Sarcoma	48
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population	47
Issue Information	46
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer	46
Physical Activity Patterns According to Demographic, Social, and Clinical Correlates Among Breast Cancer Survivors	45
Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation	45
Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma	44
Oil blotting paper for formalin fixation increases endoscopic ultrasound‐guided tissue acquisition‐collected sample volumes on glass slides	44
Intake of polyphenols from cereal foods and colorectal cancer risk in the Melbourne Collaborative Cohort Study	44
	43
Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single‐Session, Telehealth Intervention for Patients With Cancer‐Related Pain	43
Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database	43
Health‐related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma	42
Improved risk scoring systems for colorectal cancer screening in Shanghai, China	42
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age–period–cohort modeling study	42
Examining the involvement of guardians of children with acute lymphoblastic leukemia in Tanzania as public contributors to inform the design and conduct of the GuardiansCan project: A mixed	41
Body mass index and incident cardiometabolic conditions in relation to obesity‐related cancer risk: A population‐based cohort study in Catalonia, Spain	40
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis	39
Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results	39
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China	38
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer	38
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications	38
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	37
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	37
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer	37
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	36
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	35
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	35
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	35
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	35
Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer	34
Family physicians' involvement in palliative cancer care	34
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	34
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	34
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	33
Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus	33
Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: A large‐scale retrospective cohort study	32
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	32
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	32
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	32
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	32
Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patients	32
	31
Predicting Caregiver Anxiety and Depression From Patient Distress in Brain Tumor Dyads: Actor‐Partner Interdependence Model	31
Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy	31
Reasoning and causal inference regarding surgical options for patients with low‐grade gliomas using machine learning: A SEER‐based study	31
Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?	31
Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and H	31

Machine Learning‐Based Model for Predicting Recurrence‐Free Survival After Interventional Therapy in Malnourished Hepatocellular Carcinoma Patients	31
Associations of the Colon Tissue Microbiome and Circulating Bile Acids With Colorectal Adenoma Among Average‐Risk Women	31
Impact of COVID ‐19 on Time to Treat Breast Cancer and Racial Disparities Among Women in the Military Health System From FY2	31
Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on out	30
Pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis	30
Cervical Adenocarcinoma: What's Special About the Long‐Term Reproductive and Oncological Outcomes of Fertility‐Sparing Radical Trachelectomy in It?	30
The heterogeneous impact of targeted therapy on the prognosis of stage III/IV colorectal cancer patients with different subtypes of TP53 mutations	30
Efficacy of fusion imaging for immediate post‐ablation assessment of malignant liver neoplasms: A systematic review	30
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Canc	30
Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race	30
Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials	30
Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas	30
SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer	30
Evaluation of an artificial intelligence support system for breast cancer screening in Chinese people based on mammogram	29
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements	29
Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population	29
Explorative Detection of Fractional Exhaled Nitric Oxide ( FeNO ) in Exhaled Breath of Patients With Breast Cancer	29
Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy	29
Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients	29
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle‐invasive bladder cancer: A multi‐center, single‐arm, phase 2 study	29
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin/+‐induced colorectal cancer	29
Clinicopathological features of adult T‐cell leukemia/lymphoma with T‐follicular helper phenotype	29
Evaluating the impact of COVID‐19 on cancer declarations in Quebec, Canada	29
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model	29
A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer	29
Neurobiology of cancer: Definition, historical overview, and clinical implications	28
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes	28
Roles of long noncoding RNA in triple‐negative breast cancer	28
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study	28
Clinical results of active surveillance for extra‐abdominal desmoid‐type fibromatosis	28
Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method	28
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	28
Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer	28
Impacts and Pathways of Behavioral Activation on Psychological Distress Among Patients Diagnosed With Esophageal and Gastric Cancer in China: A Randomized Controlled Trial	28
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stageBRCA‐associated hormone receptor‐positive breast cancer	27
Enrichment of Cancer‐Associated Fibroblasts, Macrophages, and Up‐Regulated TNF ‐α Signaling in the Tumor Microenvironment of	27
Physical frailty deteriorates after a 5‐day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study	27
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer	27
Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy	27
Pain experience of lung cancer patients during home recovery after surgery: A qualitative descriptive study	27
Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II	27
The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis	27
Role of Exosome in Solid Cancer Progression and Its Potential Therapeutics in Cancer Treatment	27
A clinical trial to compare a 3D‐printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy	26
Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer Registry	26
Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience	26
Narrative Review of Patient Cancer Tissue–Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical Application	26
Traditional Chinese medicines and capecitabine‐based chemotherapy for colorectal cancer treatment: A meta‐analysis	26
Vaspin accelerates the proliferation, invasion and metastasis of Triple‐Negative breast cancer through MiR‐33a‐5p/ABHD2	25
Dynamic alteration and prognostic significance of tumor‐associated CD68+ and CD68+PD‐L1− macrophages in muscle‐invasive bladder cancer treated with neoadjuvant chemoth	25
Exosomal miR‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression	25
Global incidence, risk factors, and temporal trends of nasal cancer: A population‐based analysis	25
Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity	25
Clinical factor‐based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix	25
Cost‐Effectiveness of Computer‐Assisted Cytology in a Primary hrHPV‐Based Cervical Cancer Screening Programme	25
Association Between Systemic Immunity‐Inflammation Index (SII) and Fatigue, Cancer, and Cancer‐Related Fatigue: Insights From NHANES (2005–2018)	25
Uptake of genetic counseling and testing in a clinic‐based population of women with breast cancer	25
Sex‐based immune microenvironmental feature heterogeneity in response to PD‐1 blockade in combination with chemotherapy for patients with untreated advanced non‐small‐cell lung cancer	25
A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncolo	24
Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia	24
Fertility preservation in male adolescents with cancer (2011–2020): A retrospective study in China	24
Correction to Fat mass and obesity‐associated protein regulates tumorigenesis of arecoline‐promoted human oral carcinoma	24
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak	24
Potentially functional variants of ERRFI1 in hypoxia‐related genes predict survival of non‐small cell lung cancer patients	24
Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan‐cancer analysis	24
A New Approach to Ultra‐Low Anterior Resection—Intersphincteric Dissection With Total Hiatal Ligament Excision for Very Low Rectal Cancer Located in the Posterior Wall of the Rectum: A More Satisfacto	24
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II<	24
Primary care patient interest in joining a planned multi‐cancer early detection clinical trial	24
Utilization of Radical Prostatectomy Versus Radiation Therapy for Gleason Grade Group 5 Prostate Cancer Before and After USPSTF Grade D Recommendation Against Prostate‐Specific Antigen Scre	24
An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes	24
Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway	24
Issue Information	24
Tracing the evolving dynamics and research hotspots in the kidney neoplasm and nephron sparing surgery field from the past to the new era	24
Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis	23
Prognosis of high‐risk human papillomavirus‐related cervical lesions: A hidden Markov model analysis of a single‐center cohort in Japan	23
Correction to: Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study	23
Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study	23
	23
RETRACTED: LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expr	23
Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants	23

Real‐life challenges using personalized prognostic scoring systems in acute myeloid leukemia	22
The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan	22
Second‐line treatment options in advanced thymic carcinoma after failure of platinum‐based chemotherapy: A multicenter retrospective study	22
Clear cell renal cell carcinoma molecular variations innon‐HispanicWhite and Hispanic patients	22
HBcAb positivity increases the risk of postoperative complications after extended hemihepatectomy for hilar cholangiocarcinoma	22
Efficacy of gemcitabine in combination with nanoparticle albumin‐bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review	22
Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study	22
SGK1 mutation status can further stratify patients with germinal center B‐cell‐like diffuse large B‐cell lymphoma into different prognostic subgroups	22
Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma	22
A multicenter phase II trial of primary prophylactic PEG‐rhG‐CSF in pediatric patients with solid tumors and non‐Hodgkin lymphoma after chemotherapy: An interim analys	22
Impact of COVID‐19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase	22
β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma	21
	21
Different patients, different preferences: A multicenter assessment of patients' personality traits and anxiety in shared decision making	21
BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010–2013: An observational study using state cancer registry and All‐Payer claims data	21
HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma	21
Detection of methylated BCAT1 and IKZF1 after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence	21
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer	21
Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis	21
miR‐155‐regulated mTOR and Toll‐like receptor 5 in gastric diffuse large B‐cell lymphoma	21
Intraductal papillary carcinoma of breast with invasion: A nomogram and survival from the analysis of the SEER database	21
Immune‐related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia	21
TWEAK/Fn14 Drives Tumor Progression and Is Associated With Poor Survival of Colorectal Liver Metastases With Replacement Growth Patterns	21
	21
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma	21
MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients	21
Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China	21
Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma	21
Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling	21
Developing Individualized Follow‐Up Strategies Based on High‐Risk Recurrence Factors and Dynamic Risk Assessment for Locally Advanced Rectal Cancer	21
Identification of a novel nine‐SnoRNA signature with potential prognostic and therapeutic value in ovarian cancer	20
Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway	20
The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer	20
Cancer inequalities in incidence and mortality in the State of São Paulo, Brazil 2001–17	20
Examining inequities associated with incarceration among breast cancer patients	20
Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study	20
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas	20
NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon‐α2b Treatment	20
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity	20
Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma	20
Carcinoid tumors outside the abdomen	20
A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation	20
Quality of integrated female oncofertility care is suboptimal: A patient‐reported measurement	20
Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib	20
Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers	20
Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma	19
Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer	19
Extracellular Volume Fraction Combined With Pathological Features of α‐SMA and FAP for Predicting the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma After Surgery and Evaluating the Effic	19
Non‐Invasive Tumor‐Naïve Minimal Residual Disease Detection of Liver Cancer by Incorporating Circulating Tumor DNA Features and Alpha‐Fetoprotein: A Prospective Study	19
miR‐34a promotes the immunosuppressive function of multiple myeloma‐associated macrophages by dampening the TLR‐9 signaling	19
Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG‐RC20‐06	19
Prognostic value of tumor‐infiltrating lymphocytes and PD‐L1 expression in esophageal squamous cell carcinoma	19
Gastric cancer‐associated long non‐coding RNA profiling and noninvasive biomarker screening based on a high‐risk population cohort	19
Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer	19
Long‐Term Observation of Orbital Development in Patients With Retinoblastoma Following Unilateral Enucleation	19
The Effect of Financial Toxicity on the Association Between Perceived Social Support and Negative Emotions in Post‐Surgical Lung Cancer Patients: A Cross‐Sectional Study From High‐Middle Income Region	19
Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma	19
Pilot study of implementing the Shared Healthcare Actions & Reflections Electronic systems in Survivorship (SHARE‐S) program in coordination with clinical care	19
Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis	19
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials	19
Do corticosteroids affect immunotherapy efficacy in malignancy? – A systematic review	19
High expression of caspase‐8 as a predictive factor of poor prognosis in patients with esophageal cancer	19
Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial	19
Quality of life and patient‐reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy	19
Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults and children: A claims‐based analysis	19
Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort study	19
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer	19
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies	19
Exploring the perspective of adolescent childhood cancer survivors on follow‐up care and their concerns regarding the transition process—A qualitative content analysis	19
Reproductive concerns among adolescent and young adult cancer survivors: A scoping review of current research situations	19
Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision‐making?	19
Incidence and prevalence of musculoskeletal health conditions in survivors of childhood and adolescent cancers: A report from the Swiss childhood cancer survivor study	19
Disproportionately high failure to rescue rates after resection for colorectal cancer in the geriatric patient population – A nationwide study	18
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation	18
Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer	18
Immune Cell Profiling Reveals a Common Pattern in Premetastatic Niche Formation Across Various Cancer Types	18
Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors	18
Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 Pathway	18
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi‐Center Analysis (YPB‐003)	18
The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency	18
Examining the role of pre‐visit anxiety on patient uncertainty and breast cancer patient–provider communication	18
CD79BY196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma	18
Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot‐assisted radical prostatectomy	18
Pretreatment Fatigue in Breast Cancer Patients: Comparison With Healthy Controls and Associations With Biopsychosocial Variables	18
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study	18
Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients	18
Elevated Neutrophil‐to‐Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma	18
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development	18
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity	18
Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma	18
Understanding the financial cost of cancer clinical trial participation	18
Early Termination of Oncology Clinical Trials in the United States	18
Survival and prognostic factors of early‐stage non‐small cell lung cancer in Central and Eastern Europe: A prospective cohort study	18
Recent Developments and Evolving Therapeutic Strategies in KMT2A‐Rearranged Acute Leukemia	18
Investigation on the regulatory T cells signature and relevant Foxp3/STAT3 axis in esophageal cancer	18